Bryan S. Yeung
10 Biopolis Road, #05-01 Chromos
138670, Singapore
138670, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.
Journal: Science translational medicine
Published: February 28, 2020
Hepatic spheroids used as an in vitro model to study malaria relapse.
Journal: Biomaterials
Published: March 26, 2019
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages.
Journal: Nature communications
Published: October 22, 2018
Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hit.
Journal: Bioorganic & medicinal chemistry letters
Published: January 10, 2017
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes.
Journal: Nature microbiology
Published: June 03, 2016
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites.
Journal: Scientific reports
Published: March 03, 2016
PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.
Journal: Antimicrobial agents and chemotherapy
Published: January 04, 2016
Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases.
Journal: Nature reviews. Drug discovery
Published: June 02, 2015
Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.
Journal: Antimicrobial agents and chemotherapy
Published: December 10, 2014
Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages.
Journal: ACS medicinal chemistry letters
Published: June 09, 2014
Last Updated: 09/26/2026